leisure time -WSS

leisure time

author：focus 2025-10-01 02:14:28 - browse：3

Bill Cassidy speaks with his palm facing upward during a hearing on prescription drug costs — politics coverage from STAT — Sen. Bill Cassidy (R-La.) Kevin Dietsch/Getty Images

WASHINGTON — Republicans in Congress might try to use a technical maneuver to block the Biden administration from using so-called march-in rights to seize pharmaceutical patents and lower drug prices.

The Biden White House wants to ignore certain patents for inventions that were developed with government funding, at least in extenuating circumstances. Taxpayers have helped fund the research of a substantial number of drugs sold in the United States though the National Institutes of Health, so the proposal would let the government bring in generic drugmakers to make medicines even before their patents expire.

Until the Biden administration, the government refused to consider that an invention’s price could justify the “march in” maneuver. But the White House in December issued a draft framework for the NIH to more broadly use the power, including in cases where price is a concern.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

explore

WSS

Complete sequence of Y chromosome published for first time

An innovative path out of biotech’s “valley of death”

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Psilocybin's anti

Study finds new variant for Parkinson’s in African populations

Novo acquires Inversago for up to $1 billion

focus

leisure time

focus

Related: Reanimated hearts donated after death work just as well for transplants, study finds

Apellis safety probe of eye disease drug centers on injection needle

Anesthesiologist group: stop taking Ozempic before surgery

Genentech weighs delaying cancer therapy after drug pricing law

United colonoscopy coverage change 'may cost lives,' doctors say

AstraZeneca challenges Medicare drug negotiation program

Alkermes shareholders re

Diversity in medical illustrations gets boost from Chidiebere Ibe

Sports medicine is finally prioritizing gender equality

CDC overhauls leadership of center that led response to Covid

entertainment

What AAP's gender

CDC advisory panel says seniors 'may' get RSV vaccine

How to make Best Hospitals ratings actually useful for patients

Covid's long

NYU Langone launches private ChatGPT for its health care data

Maui funeral service workers on devastation of fires: 'I'm in shock'

explore

Wikipedia

explore

knowledge